NEW YORK (Reuters Health) – A multicenter center study has shown that adding cetuximab to neoadjuvant chemotherapy and preoperative radiotherapy improves overall survival after excision of high-risk rectal…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing percutaneous coronary intervention, adverse event rates are similar with either drug-eluting stents (DESs) or bare metal stents…
NEW YORK (Reuters Health) – Warming contrast medium from room temperature to body temperature reduces pain experienced during hysterosalpingography and the occurrence of vasovagal episodes, according to the…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing mechanical valve replacement, performing a concomitant Maze procedure during surgery reduces the rate of subsequent thromboembolic events,…
NEW YORK (Reuters Health) – In general, adding pemetrexed to cisplatin therapy does not improve overall survival (OS) in patients with recurrent or metastatic head and neck cancer,…
NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of…
NEW YORK (Reuters Health) – Cigarette smoking enhanced the effects of clopidogrel in a study of diabetics with coronary artery disease. Accordingly, smokers were less likely to experience…
NEW YORK (Reuters Health) – Real-world outcomes among patients with stable coronary disease favor percutaneous coronary intervention over routine medical care alone, according to data maintained by the…
NEW YORK (Reuters Health) – An investigational phosphodiesterase type 5 (PDE5) inhibitor, avanafil, is an effective and well tolerated treatment for erectile dysfunction (ED), according to the results…
NEW YORK (Reuters Health) – Results of a meta-analysis show that in preterm infants with respiratory distress syndrome, early use of nasal intermittent positive pressure ventilation (NIPPV) compared…
